Document:

<PAGE>
                                                                   EXHIBIT 10.65

                              EMPLOYMENT AGREEMENT

         THIS EMPLOYMENT AGREEMENT (the "Agreement") is made as of November 12,
2002 (the "Effective Date") by and between Gen-Probe Incorporated, a Delaware
corporation with offices at 10210 Genetic Center Drive, San Diego, California
92121 ("Gen-Probe"), and [NAME] (the "Executive").

         WHEREAS, the Executive is currently employed as an officer of
Gen-Probe;

         WHEREAS, prior to September 15, 2002, Gen-Probe was a wholly-owned
subsidiary of Chugai Pharmaceutical Co., Ltd.;

         WHEREAS, Chugai distributed its Gen-Probe shareholdings to its
shareholders in a "spin off" transaction on September 15, 2002; and

         WHEREAS, the Board of Directors of Gen-Probe (the "Board"), having
considered the proposed spin-off transaction and other circumstances, deems it
in the best interest of Gen-Probe to offer this Agreement to the Executive and
the Executive desires to enter into this Agreement.

         ACCORDINGLY, the parties hereto agree as follows:

1.       TERM OF EMPLOYMENT. This Agreement shall be immediately effective. This
         Agreement, and Executive's employment hereunder, shall be for an
         indefinite term. At any time during the term of this Agreement, either
         party may terminate this Agreement, and Executive's employment, in
         accordance with the provision of Sections 6 and 7 of this Agreement.

2.       POSITION AND DUTIES. The Executive shall serve as [TITLE] of Gen-Probe,
         and shall have commensurate responsibilities and authority. The Board
         of Directors may from time to time particularly specify the Executive's
         duties and authority. The Executive shall not engage in or perform
         duties for any other persons or entities that interfere with the
         performance of his duties hereunder. Any outside board of director
         positions held by the Executive will be subject to approval by the
         Board of Directors of Gen-Probe.

                                       1
<PAGE>

3.       SALARY, BONUS AND BENEFITS.

         (a) SALARY. During the period of the Executive's employment, Gen-Probe
             shall pay him an annual base salary at the rate the Executive is
             being paid as of the Effective Date. This base salary may be
             adjusted annually by the Board, subject to the terms of this
             Agreement and consistent with the Executive's performance and
             Gen-Probe's policy regarding adjustments in officer compensation
             established from time to time by the Board.

         (b) BONUS. In addition, at the Board's discretion, the Executive may be
             awarded incentive compensation, in the form of a cash bonus for
             each fiscal year during his employment, based upon performance.

         (c) BENEFITS. The Executive shall be entitled to participate in the
             employee benefit programs (including but not limited to medical,
             dental, life and disability insurance, 401K retirement plan, and
             vacation program), which may be adopted and maintained by
             Gen-Probe. The Executive may receive such other and additional
             benefits as the Board may determine from time to time in its sole
             discretion.

4.       EXPENSE REIMBURSEMENT. The Executive shall be entitled to receive
         prompt reimbursement for all reasonable and customary expenses incurred
         by him in performing services hereunder, including all expenses of
         travel and living expenses while away from home on business or at the
         request of, and in the service of Gen-Probe; provided, that such
         expenses are incurred and accounted for in accordance with the policies
         and procedures established by Gen-Probe.

5.       INDEMNIFICATION. Gen-Probe shall indemnify the Executive to the maximum
         extent permitted by law and by the by-laws of Gen-Probe if the
         Executive is made a party, or threatened to be made a party, to any
         threatened or pending legal action, suit or proceeding, whether civil,
         criminal, administrative or investigative, by reason of the fact that
         the Executive is or was an officer, director or employee of Gen-Probe
         or any subsidiary or affiliate thereof, in which capacity the Executive
         is or was serving at Gen-Probe's request, against reasonable expenses
         (including reasonable attorneys' fees), judgments, fines and settlement
         payments incurred by him in connection with such action, suit or
         proceeding.

6.       TERMINATION. The Executive may terminate his employment hereunder at
         any time, with or without Good Reason (as defined below) upon written
         notice to Gen-Probe. If Executive contends that Good Reason exists for
         his termination, such notice shall specifically and expressly state the
         grounds which he contends constitute Good Reason. Gen-Probe may
         terminate the Executive's employment hereunder at any time, subject to
         the terms of this Agreement, with or without Cause (as defined below)
         upon written notice to the Executive. If this Agreement is terminated,
         all compensation and benefits other than severance benefits

                                       2
<PAGE>

         described in Section 7 below, to the extent applicable, shall
         immediately cease, except that the Executive will be entitled, through
         the date of termination, to payment of his salary and benefits under
         Gen-Probe benefit programs and plans in accordance with their terms.

         As used in this Agreement, "Good Reason" shall mean any of the
         following events that are not consented to by the Executive: (i) a
         substantial and material diminution in the Executive's duties and
         responsibilities hereunder; (ii) the location of the Executive's
         assignment on behalf of Gen-Probe is moved to a location more than 30
         miles from its present location; (iii) a reduction of more than ten
         percent (10%) in the Executive's base salary or in the Executive's
         benefits received from Gen-Probe; (iv) the failure of Gen-Probe to
         obtain a satisfactory agreement from any other successor to Gen-Probe
         to assume and agree to perform this Agreement; or (iv) a material
         breach by Gen-Probe of its obligations under this Agreement after
         notice in writing from the Executive and a reasonable opportunity for
         Gen-Probe to cure or substantially mitigate any material adverse effect
         of such breach. The Executive's consent to any event which would
         otherwise constitute Good Reason shall be conclusively presumed if the
         Executive does not exercise his rights to terminate this Agreement for
         Good Reason under this section within ninety (90) days of notice of the
         event.

         As used in this Agreement, "Cause" shall mean any of the following
         events: (i) any act of gross or willful misconduct, fraud,
         misappropriation, dishonesty, embezzlement or similar conduct on the
         part of Executive; (ii) the Executive's conviction of a felony or any
         crime involving moral turpitude (which conviction, due to the passage
         of time or otherwise, is not subject to further appeal); (iii) the
         Executive's misuse or abuse of alcohol, drugs or controlled substances
         and failure to seek and comply with appropriate treatment; (iv) willful
         and continued failure by the Executive to substantially perform his
         duties under this Agreement (other than any failure resulting from
         disability or from termination by the Executive for Good Reason) as
         determined by a majority of the Board after written demand from the
         Board of Directors for substantial performance is delivered to the
         Executive, and the Executive fails to resume substantial performance of
         his duties on a continuous basis within 30 days of such notice; (vi)
         the death of the Executive; or (vii) the Executive becoming disabled
         such that he is not able to perform his usual duties for Gen-Probe for
         a period in excess of six (6) consecutive calendar months.

                                       3
<PAGE>

7.       SEVERANCE BENEFITS IN CERTAIN EVENTS. If Gen-Probe terminates the
         Executive's employment for reasons other than Cause, or if the
         Executive terminates his employment for Good Reason, the Executive
         shall be entitled to receive as liquidated damages, the following
         severance benefits:

         (a) SALARY. The Executive shall continue to receive his base salary, at
             the rate in effect at the time of his termination of employment, in
             monthly installments commencing the first day of the first month
             following termination and continuing for an aggregate period of six
             (6) months (the "Salary Continuation Period"); provided, however,
             that if termination under this Section 7 occurs in connection with
             a Change in Control, then the Executive shall receive a single lump
             sum payment, payable within 10 days of termination, equal to twelve
             (12) months' base salary.

             For purposes of this Agreement, "Change in Control" shall have the
             meaning set forth on Attachment "1" to this Agreement (hereby
             incorporated by reference). For purposes of this Agreement, a
             termination shall be "in connection with" a Change in Control if
             termination occurs within the period six (6) months prior to or
             eighteen (18) months after a Change in Control.

         (b) BONUS. If termination under this Section 7 occurs in connection
             with a Change in Control then the Executive shall be entitled to
             receive, in lieu of the bonus provided in Section 3(b) and in
             addition to the salary payment described in Section 7(a), above, an
             amount equal to the greater of (i) the Executive's targeted level
             bonus in the year of the termination, or (ii) the Executive's
             highest discretionary bonus in the preceding three years. The
             amount payable shall be paid in the same manner as and on the same
             schedule as the salary compensation paid under subsection (a)
             above. No bonus compensation shall be payable under this section 7
             unless termination occurs in connection with a change in control.

         (c) HEALTH CARE AND LIFE INSURANCE COVERAGE. Continued health care
             coverage under Gen-Probe's medical plan will be provided, without
             charge, to the Executive and his eligible dependents until the
             earlier of (i) one (1) year following the termination date or (ii)
             the first date that the Executive is covered under another
             employer's health benefit program providing substantially the same
             or better benefit options to the Executive without exclusion for
             any pre-existing medical condition. The period of time medical
             coverage continues under this agreement will be counted as coverage
             time under COBRA. Gen-Probe will pay the premium for continued life
             insurance coverage, if any, that the Executive may have elected
             under Gen-Probe's Life Insurance and Supplemental Life Insurance
             plan, subject to payment by the Executive of the portion of such
             premium not contributed by Gen-Probe under such plan, during the
             Salary Continuation Period.

                                       4
<PAGE>

         (d) 401(K) PLAN. The Executive's interest in any unvested contributions
             made by Gen-Probe to the Executive's 401(k) account shall vest as
             of the date of termination.

         (e) OUTPLACEMENT SERVICES. Gen-Probe agrees to provide Executive with
             outplacement services during the first six months of the Salary
             Continuation Period.

         (f) TAX MATTERS. All compensation described in this Section 7 will be
             subject to Gen-Probe's collection of all applicable federal, state
             and local income and employment withholding taxes. If any excise
             tax is imposed under Section 4999 in connection with the
             compensation described in this Section 7 and/or in connection with
             the acceleration upon severance of any stock options granted by
             Gen-Probe to the Executive, Executive shall be solely responsible
             for any such excise tax.

         (g) RELEASE OF CLAIMS. Gen-Probe's obligation to make the payments and
             provide the benefits hereunder shall be conditioned upon
             Executive's execution of a release of all claims, in standard form
             and content. The release shall be mutual and shall also be signed
             on behalf of Gen-Probe.

8.       MISCELLANEOUS.

         (a) ARBITRATION. Executive and Gen-Probe agree that any and all claims
             or disputes that in any way relate to or arise out of ------------
             Executive's employment with Gen-Probe or the termination of such
             employment (including but not limited to claims under this
             Agreement or any other contract, tort claims, and statutory claims
             of employment discrimination, retaliation or harassment) shall be
             resolved exclusively through final and binding arbitration in San
             Diego, California. Executive and Gen-Probe waive any rights to a
             jury trial in connection with such claims or disputes. The costs of
             the arbitration, including the fees of the arbitrator, shall be
             borne exclusively by Gen-Probe. Any such arbitration shall take
             place in San Diego, California and shall be conducted by a single
             neutral arbitrator who shall be a retired federal or state judge,
             to be appointed by Judicial Arbitration and Mediation Services
             ("JAMS") in accordance with JAMS rules. The applicable procedural
             rules of JAMS shall govern the arbitration. The arbitrator's
             decision shall be delivered in writing and shall disclose the
             essential findings and conclusion on which the arbitrator's
             decision is based. The parties shall be permitted to conduct
             adequate discovery to allow for a full and fair exploration of the
             issues in dispute in the arbitration proceeding. The arbitrator may
             grant any relief which otherwise would have been available to the
             parties in a court proceeding. The decision and award of the
             arbitrator shall be final and binding, and judgment upon the
             arbitrator's award may be entered by any court of competent
             jurisdiction.

                                       5
<PAGE>

         (b) GOVERNING LAW. This Agreement shall be construed and enforced in
             accordance with and be governed by the laws of the State of
             California.

         (c) ENTIRE AGREEMENT. This Agreement sets forth the entire Agreement
             and understanding between the Executive and the Company on the
             subject matter hereof, and supersedes any other negotiations,
             agreements, understandings, oral agreements, representations and
             past or future practices whether written or oral. No provision of
             this Agreement may be amended, supplemented, modified, cancelled,
             or discharged unless such amendment, supplement, modification,
             cancellation or discharge is agreed to, in writing, signed by the
             Executive and a duly authorized officer of the Company (other than
             the Executive); and no provisions hereof may be waived, except in
             writing, so signed by or on behalf of the party granting such
             waiver.

         (d) VALIDITY. The invalidity or unenforceability of any provision or
             provisions of this Agreement shall not affect the validity or
             enforceability of any other provision of this Agreement, which
             shall remain in full force and effect.

         (e) NOTICES. For the purposes of this Agreement, notices, demands and
             all other communications provided for in this Agreement shall be in
             writing and shall be deemed to have duly given when personally
             delivered or mailed by United States certified or registered mail,
             return receipt requested, postage prepaid, addressed as follows:

             If to the Executive:

                                          [ADDRESS]

             If to Gen-Probe:

                                          President and Chief Executive Officer
                                          Gen-Probe Incorporated
                                          10210 Genetic Center Drive
                                          San Diego, California 92121

                          With a copy to:

                                          General Counsel
                                          Gen-Probe Incorporated
                                          10210 Genetic Center Drive
                                          San Diego, California 92121

                                       6
<PAGE>

         (f) SUCCESSORS. Gen-Probe will require any successor (whether direct or
             indirect, by purchase, merger, consolidation or otherwise) to all
             or substantially all the business and/or assets of Gen-Probe, by
             agreement in form and substance satisfactory to the Executive,
             expressly to assume and agree to perform this Agreement in the same
             manner and to the same extent that Gen-Probe would be required to
             perform it if no such succession had taken place. This Agreement
             and all rights under the Agreement shall be binding upon and shall
             inure to the benefit of and be enforceable by the party's personal
             or legal representatives, executors, administrators, heirs, and
             successors.

         (g) NO RIGHT TO CONTINUED EMPLOYMENT. Nothing herein shall be construed
             as giving the Executive any rights to continued employment with
             Gen-Probe, and Gen-Probe shall continue to have the right to
             terminate the Executive's employment at any time, with or without
             cause, subject to the provisions of this Agreement.

         In witness whereof, the parties have executed this Agreement.

Executive:                                  Gen-Probe Incorporated:

____________________________                By __________________________
[NAME]                                      Henry L. Nordhoff
                                            Chairman, President and
                                            Chief Executive Officer

                                       7
<PAGE>

                                 ATTACHMENT "1"

                        DEFINITION OF "CHANGE IN CONTROL"

                  Change in Control. "Change in Control" shall mean a change in
ownership or control of the Company effected through any of the following
transactions:

         (a)      any person or related group of persons (other than the Company
or a person that, prior to such transaction, directly or indirectly controls, is
controlled by, or is under common control with, the Company) directly or
indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under
the Exchange Act) of securities possessing more than fifty percent (50%) of the
total combined voting power of the Company's outstanding securities by means of
any transaction or series of transactions; or

         (b)      there is a change in the composition of the Board over a
period of thirty-six (36) consecutive months (or less) such that a majority of
the Board members (rounded up to the nearest whole number) ceases, by reason of
one or more proxy contests for the election of Board members, to be comprised of
individuals who either (i) have been Board members continuously since the
beginning of such period or (ii) have been elected or nominated for election as
Board members during such period by at least a majority of the Board members
described in clause (i) who were still in office at the time such election or
nomination was approved by the Board; or

         (c)      the stockholders of the Company approve a merger or
consolidation of the Company with any other corporation (or other entity), other
than a merger or consolidation which would result in the voting securities of
the Company outstanding immediately prior thereto continuing to represent
(either by remaining outstanding or by being converted into voting securities of
the surviving entity or another entity) more than 66-2/3% of the combined voting
power of the voting securities of the Company or such surviving entity
outstanding immediately after such merger or consolidation; provided, however,
that a merger or consolidation effected to implement a recapitalization of the
Company (or similar transaction) in which no person acquires more than 25% of
the combined voting power of the Company's then outstanding voting securities
shall not constitute a Change in Control; or

         (d)      the stockholders of the Company approve a plan of complete
liquidation of the Company or an agreement for the sale or disposition by the
Company of all or substantially all of the Company's assets.

                                       8
<PAGE>

Schedule to Exhibit 10.65

The preceding form of Employment Agreement was entered into between the Company
and the following individuals:
<TABLE>
<CAPTION>
NAME                       TITLE                                       EXECUTION DATE
<S>                        <C>                                         <C>
Lyle J. Arnold             Vice President - Research                   January 12, 2004
Martin B. Edelshain        Vice President - Corporate Development      November 11, 2003
Paul E. Gargan             Vice President - Business Development       November 12, 2002
Gurney I. Lashley          Vice President - Supply Chain               November 12, 2002
Mathew Longiaru            Vice President - Product Development        November 12, 2002
Mark A. Powelson           Vice President - Worldwide Sales            January 12, 2004
Stephen M. Prince          Vice President - Marketing                  January 12, 2004
Peter R. Shearer           Vice President - Intellectual Property      November 12, 2002
Donald D. Tartre           Vice President - Finance and
                            Corporate Controller                       January 19, 2004
</TABLE>

                                       9DEFERRED STOCK UNIT & STOCK OPTION PLAN

 

Exhibit 10.32

MERRILL LYNCH & CO., INC. DEFERRED STOCK UNIT AND STOCK OPTION PLAN FOR NON-

EMPLOYEE DIRECTORS

Article I — General

          Section 1.1     Purposes.

                    The purposes of the Merrill Lynch & Co., Inc. Deferred Stock Unit and
Stock Option Plan for Non-Employee Directors, as amended (the “Plan”), are (a)
to provide an incentive to highly qualified individuals to serve as Directors
of Merrill Lynch & Co., Inc. (“ML & Co.”), and (b) to further align the
interests of Non-Employee Directors with the stockholders of ML & Co.

          Section 1.2     Definitions.

     For purposes of the Plan, the following terms shall have the meanings
indicated.

     “Account” means a notional account recording grants of Deferred Units
and Deferred Stock Units under the Plan.

     “Account Balance” means the balance of a Participant’s Account
reflecting Deferred Units and Deferred Stock Units credited to a
Participant’s Account, adjusted in accordance with Section 3.1 to reflect
the addition of dividend equivalents and any changes in capitalization and
adjusted for any payments to the Participant.

     “Administrator” means the Head of Human Resources of ML & Co., or his
or her functional successor.

     “Affiliate” means any corporation, partnership, or other organization
of which ML & Co. owns or controls, directly or indirectly, not less than
50% of the total combined voting power of all classes of stock or other
equity interests.

     “Annual Meeting” means the Annual Meeting of Stockholders of ML & Co.

     “Board of Directors” or “Board” shall mean the Board of Directors of
ML & Co.

     “Business Day” shall mean any day on which the New York Stock
Exchange is open for business.

     “Change in Control” means a change in control of ML & Co. of a nature
that would be required to be reported in response to Item 6(e) of Schedule
14A of Regulation 14A promulgated under the Exchange Act, whether or not
ML & Co. is then subject to such reporting requirement; provided,
however, that, without limitation, a Change in Control shall be
deemed to have occurred if:

     (a) any individual, partnership, firm, corporation, association,
trust, unincorporated organization or other entity, or any syndicate or
group deemed to be a person under Section 14(d)(2) of the Exchange Act,
other than ML & Co.’s employee stock ownership plan, is or becomes the
“beneficial owner” (as defined in Rule 13d-3 of the General Rules and
Regulations under the Exchange Act), directly or indirectly, of securities
of ML & Co. representing 30% or more of the combined voting power of ML &
Co.’s then outstanding securities entitled to vote in the election of
directors of ML & Co.;

     (b) during any period of two consecutive years (not including any
period prior to the adoption of this Plan), individuals who at the
beginning of such period constituted the Board of Directors and any new
Directors whose election by the Board of Directors or nomination for
election by the stockholders of ML & Co. was approved by a vote of at
least three quarters of the Directors then still in office who either were
directors at the beginning of the period or whose election or nomination
for election was previously so approved, cease for any reason to
constitute at least a majority thereof; or

     (c) all or substantially all of the assets of ML & Co. are liquidated
or distributed.

 

 

     “Code” means the U.S. Internal Revenue Code of 1986, as amended from
time to time.

     “Common Stock” means the Common Stock, par value $1.33 1/3 per share,
of ML & Co. and a “share of Common Stock” shall mean one share of Common
Stock together with, for so long as Rights are outstanding, one Right
(whether trading with the Common Stock or separately).

     “Company” means ML & Co. and all of its Affiliates.

     “Current Market Value” per share of Common Stock, for any date, means
the average of the Daily Market Prices of a share of Common Stock for each
Business Day for which such Daily Market Prices are available during a
period commencing on a date 21 consecutive Business Days prior to such
date and ending on the second Business Day prior to such date.

     “Daily Market Price” of shares of Common Stock on any date means: (a)
the mean of the high and low sales prices reported on the New York Stock
Exchange—Composite Tape (or, if shares of Common Stock are not traded on
the New York Stock Exchange, the mean of the high and low sales prices
reported on any securities exchange or quotation service on which the shares
of Common Stock are listed or traded) of such shares on the date in
question, or (b) if shares of Common Stock are not then listed or admitted
to trading on any securities exchange for which reported sales prices are
available, the mean of reported high bid and low asked prices on such
date, as reported by a reputable quotation service, or by The Wall Street
Journal, Eastern Edition, or a newspaper of general circulation in the
Borough of Manhattan, City and State of New York.

     “Deferred Stock Unit” or “Deferred Unit” means a unit representing ML
& Co.’s obligation to deliver one share of Common Stock in accordance with
the terms of the Plan.

     “Director” means a member of the Board.

     “Disability” means any physical or mental condition that, in the
opinion of the Administrator, renders a Director incapable of continuing
to serve on the Board.

     “End of Service Date” means the date on which a Participant ceases to
serve as a Director for any reason.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     “Executive Committee” means the Executive Committee of the Board of
Directors.

     “Holding Period” has the meaning specified in Section 2.4.

     “Initial Payment Date” has the meaning specified in Section 2.6(b).

     “Junior Preferred Stock” means ML & Co.’s Series A Junior Preferred
Stock, par value $1.00 per share.

     “Non-Employee Director” means a member of the Board who is not
employed by ML & Co. or any Affiliate of ML & Co.

     “Participant” means each Non-Employee Director to whom a grant of
Deferred Units, Deferred Stock Units, or Stock Options is made under the
Plan.

     “Retirement Payments” means the arrangements for post-retirement
payments to Non-Employee Directors adopted by ML & Co. for its
Non-Employee Directors, as amended February 16, 2001.

2

 

     “Retirement” means ceasing to serve as a Director of ML & Co. in
accordance with ML & Co’s retirement policy for Non-Employee Directors.

     “Retirement Annual Meeting” means, with respect to any Retiring
Non-Employee Director, the Annual Meeting that coincides with such
Director’s Retirement.

     “Retiring Non-Employee Director” means a Non-Employee Director whose
Retirement Annual Meeting will occur prior to, or will be the fifth Annual
Meeting following, the effective date of any grant of Deferred Units or
Deferred Stock Units to such Director.

     “Rights” means the Rights to Purchase Units of Series A Junior
Preferred Stock, par value $1.00 per share, of ML & Co. issued pursuant to
the Rights Agreement dated as of December 16, 1987 between ML & Co. and
Manufacturers Hanover Trust Company, Rights Agent, as amended from time to
time.

     “Stock Option” means a right, granted to a Non-Employee Director,
pursuant to Section 2.4 hereof, to purchase prior to a specified date and
at a specified price a specified number of shares of Common Stock.

     “Tender Offer” means an offer to purchase all or a portion of the
outstanding shares of Common Stock that is subject to Section 14D of the
Exchange Act, provided that such offer, if consummated, would result in a
Change in Control.

          Section 1.3     Shares Subject to the Plan.

          The total number of shares of Common Stock that shall be reserved for
issuance in payment of Deferred Stock Units under the Plan shall be 800,000,
subject to automatic adjustment for changes in capitalization of ML & Co. as
provided in Section 3.1 hereof. Shares of Common Stock issued under the Plan
shall only be shares previously issued and reacquired by ML & Co. and held in
its treasury.

Article II — Deferred Units, Deferred Stock Units, and Stock Options; Optional Deferral of Payment

          Section 2.1     Deferred Unit Grants.

          (a)     Five-Year Initial Grants. (i) Effective February 16, 2001, no further
grants will be made under this Section 2.1(a). Grants previously made under
this Section 2.1(a) shall be payable in shares of Common Stock of the Company
and otherwise remain outstanding and payable in accordance with their terms.
(ii) Each Non-Employee Director who was a member of the Board on August 1,
1996 was granted, as of August 1, 1996, the number of Deferred Units obtained
by dividing $50,000 by the Current Market Value per share of Common Stock on
such date (with the result rounded upwards to the nearest whole Deferred
Unit).

          (b)     Five-Year New Director Grants. (i) Effective February 16, 2001, no
further grants will be made under this Section 2.1(b). Grants previously made
under this Section 2.1(b) shall be payable in shares of Common Stock of the
Company and otherwise remain outstanding in accordance with their terms. (ii)
Each person who became a Non-Employee Director between August 1, 1996 until
February 16, 2001, as of the date when such person became a Non-Employee
Director, was granted the number of Deferred Units obtained by dividing
$50,000 (adjusted downward in the event that such directors Retirement would
have been within 5 years of the grant) by the Current Market Value per share
of Common Stock on such date (with the result rounded rounding the result
upwards to the nearest whole Deferred Unit).

          (c)     Annual Grants. (i) Effective February 16, 2001 no further grants
will be made under this Section 2.1(c). Grants previously made under this
Section 2.1(c) shall be payable in shares of Common Stock of the Company and
otherwise remain outstanding in accordance with their terms. (ii) During the
period between April 1, 1998 and February 16, 2001 (effective on the close of
business on the first Business Day of the month next following the date of
each Annual Meeting) any Director then serving as a Non-Employee Director was
granted, without any action by the Board of Directors, on such date the number
of Deferred Units obtained by dividing $10,000 by the Current Market Value per
share of Common Stock on such date (with the

3

 

result rounded upwards to the nearest whole Deferred Unit). (iii) Each person
who became a Non-Employee Director during such period on a date other than the
date of an Annual Meeting, was granted, on the date when such person became a
Non-Employee Director and without any action by the Board of Directors, the
number of Deferred Units obtained by dividing $10,000 by the Current Market
Value per share of Common Stock on such date (with the result rounded upwards
to the nearest whole Deferred Unit).

          Section 2.2     Five-Year Deferred Stock Unit Grants.

          Effective February 16, 2001 no further grants will be made under this
Section 2.2. Grants previously made under this Section 2.2 shall be payable in
shares of Common Stock of the Company and otherwise remain outstanding in
accordance with their terms. During the period between October 26, 1996 and
February 16, 2001, without any action by the Board of Directors:

	 	(i)	 	each Non-Employee Director who had received a grant under
the Merrill Lynch & Co., Inc. Non-Employee Director’s Equity Plan,
(“Equity Plan”) effective on the close of business on the first
Business Day of the month next following the date of the Annual
Meeting upon which such Director’s grant became fully vested and

	 	(ii)	 	each Non-Employee Director who had not received a grant
under the Equity Plan, effective on the date that such Director
joined the Board of Directors

was granted the number of Deferred Stock Units obtained by dividing
$50,000 by the Current Market Value per share of Common Stock on such
date and rounding the result upwards to the nearest whole Deferred Stock
Unit, provided, however, that, in each case, the dollar
amount used to determine the grant to any Retiring Non-Employee Director
was $50,000 multiplied by the Retirement Fraction applicable to such
Retiring Non-Employee Director.

          Section 2.3     Annual Deferred Stock Unit Grants.

          (a)     Regular Grants. Each Non-Employee Director who (i) is a member of the
Board on February 26, 2001, and makes an election (in accordance with
procedures set forth by the Administrator) to receive no further increases in
his or her retirement payments, or (ii) is appointed or elected to the Board
following February 26, 2001, shall, without any further action by the Board of
Directors, receive as of the date of every subsequent Annual Meeting for which
he or she is a Continuing Director, the number of Deferred Stock Units
obtained by dividing $72,500 by the Daily Market Price per share of Common
Stock on such date and rounding the result upwards to the nearest whole
Deferred Stock Unit.

          (b)     Prorated Mid-Year Regular Grants. A Non-Employee Director who joins
the Board after the date of an Annual Meeting, shall without any further
action by the Board of Directors receive a pro-rated regular grant. The value
of such grant shall be computed by multiplying $72,500 by a fraction the
numerator of which shall be the number of months that remain until the
Corporation’s Annual Meeting and the denominator of which shall be 12. The
number of Deferred Stock Units to be granted shall be determined by dividing
the dollar value obtained from the calculation in the previous sentence by
the Daily Market Price per share of Common Stock on the date of his or her
appointment to the Board.

          (c)     Adjusted
Grants. Each Non-Employee Director who is a member of the
Board on February 26, 2001, and makes an election (in accordance with
procedures determined by the Administrator) to continue to receive increases
in his or her retirement payments shall, without any further action by the
Board of Directors receive (i) as of April 27, 2001, and (ii) as of the date
of every subsequent Annual Meeting, the number of Deferred Stock Units
obtained by dividing $42,500 by the Daily Market Price per share of Common
Stock on such date and rounding the result upwards to the nearest whole
Deferred Stock Unit.

          (d)     Further Adjustment. The dollar amounts for the Deferred Stock Unit
grants specified in subsections (a) and (b) above shall be reduced by $10,000
each year in which Deferred Stock Units and Deferred Units granted prior to
February 16, 2001 under Sections 2.1 or 2.2 of this Plan remain subject to the
five-year Holding Period determined for such awards under Section 2.4.

4

 

          Section 2.4     Payment of Awards Upon Expiration of the Holding Period.

          Unless deferred at the option of the Participant in accordance with
Section 2.6(a) hereof, the Account Balances will become payable upon the
expiration of the holding period with respect to such grants (the “Holding
Period”), which shall expire on the earlier of: (i) the date of the fifth
Annual Meeting following the date of such grant, and (ii) a Participant’s End
of Service Date. The Deferred Units and the Deferred Stock Units will be paid
in shares of Common Stock. One share of Common Stock will be delivered for
each Deferred Unit and Deferred Stock Unit to be paid, after rounding any
fractional unit upwards to the nearest whole share.

          Section 2.5     Stock Options.

          (a)     Regular Annual Stock Option Grants. Each Non-Employee Director who is
a member of the Board on February 26, 2001 or is appointed or elected to the
Board following February 26, 2001 shall, without any further action by the
Board of Directors receive as of the date of every subsequent Annual Meeting,
a grant of the number of Stock Options obtained by dividing $72,500 by the
Daily Market Price of the Company’s Common Stock on such date and multiplying
the result by three.

          (b)     Prorated Mid-Year Regular Grants. A Non-Employee Director who joins
the Board after the date of an Annual Meeting, shall without any further
action by the Board of Directors receive a pro-rated regular grant, effective
on the date he or she becomes a member of the Board. The value of such grant
shall be computed by multiplying $72,500 by a fraction the numerator of which
shall be the number of months that remain until the Corporation’s Annual
Meeting and the denominator of which shall be 12. The number of Stock Options
to be granted shall be determined by dividing the dollar value obtained from
the calculation in the previous sentence by the Daily Market Price per share
of Common Stock on the date of his or her appointment to the Board and
multiplying the result by three.

          (c)     Exercise Price. The exercise price for each such Stock Option shall
be the Daily Market Price of a share of Common Stock on the grant date.

          (d)     Exercise of Stock Options.

	 	(i)	 	Exercisability: Stock Options shall become
exercisable six months following the grant date. A Stock Option may
be exercised at any time from such date until the close of business
on the expiration date of the Stock Option.

	 	(ii)	 	Expiration: Each Stock Option granted shall expire
and shall no longer be exercisable after the expiration of 10 years
from the date of grant of such Stock Option.

	 	(iii)	 	Exercise in the Event of Termination of Service as a
Director: If a Non-Employee Director ceases to serve as a
Director prior to the exercise or expiration of Stock Options
granted to him or her, such Stock Options may be exercised, to the
full extent not yet exercised, regardless of whether or not then
fully exercisable, and, in the event of death, such Stock Options
may be exercised by his or her estate or beneficiaries, as the case
may be, but in no event after the expiration date of such Stock
Option.

	 	(iv)	 	Limitations on Transferability: Stock Options are
not transferable by a Non-Employee Director except to immediate
family members (or trusts or other entities established for the
benefit of immediate family members) or by will or the laws of
descent and distribution and are exercisable during his or her
lifetime only by him or her.

	 	(e)	 	Payment of Purchase Price and Tax Liability Upon Exercise; Net
Exercise Method; Delivery of Shares.

	 	(i)	 	Payment of Purchase Price: The purchase price of the shares
as to which a Stock Option is exercised shall be paid to the
Company at the time of exercise (A) in cash, (B) by delivering

5

 

	 	 	 	freely transferable shares of Common Stock already owned by the
person exercising the Stock Option for at least six months having
a total Daily Market Price on the date of exercise equal to the
purchase price, or (C) a combination of cash and shares of Common
Stock equal in value to the exercise price.

	 	(ii)	 	Net Exercise Method: A holder of an outstanding Stock
Option may also elect to exercise such Stock Option by submitting
a Notice of Exercise to the Company or its representative and
receive upon exercise of the Stock Options a number of shares of
Common Stock obtained by: (1) multiplying the number of Stock
Options to be exercised by the difference between (A) the Daily
Market Price on the date of exercise and (B) the exercise price
of the Stock Option; (2) dividing the product of these
calculations by the Daily Market Price on the date of exercise;
and (3) in any country that requires the Corporation to withhold
taxes upon such an exercise, deducting a number of shares equal
to any minimum federal, state, local or social security
withholding requirements that occur as a result of the exercise.

	 	(iii)	 	Delivery of Shares: Upon receipt by the Company of the
purchase price or upon exercise in accordance with Section
2.5(e)(ii), stock certificate(s) for the shares of Common Stock
as to which a Stock Option is exercised shall be delivered to the
person in whose name the Stock Option is outstanding or such
person’s estate or beneficiaries, as the case may be, or such
 shares shall be credited to a brokerage account or otherwise
delivered, in such manner as such person or such person’s estate
or beneficiaries, as the case may be, may direct.

          Section 2.6     Optional Deferral of Payment.

          (a)     Optional Deferral of Payment. A Participant shall have the option to
defer the payment of all or a portion of any Deferred Unit or Deferred Stock
Unit grant upon the expiration of the relevant Holding Period for later
payment in accordance with this Section 2.6 by submitting to the Administrator
or his or her designee such forms as the Administrator shall prescribe by no
later than one year prior to the expiration of the relevant Holding Period.
With respect to Deferred Units and Deferred Stock Units, a Participant may
elect to have all or a portion of his or her Account Balance retained as
Deferred Stock Units in his or her Account for payment at a later date. A
Participant shall also have the right to defer the gain on exercise of a stock
options in accordance with the terms of the Merrill Lynch Stock Option Gain
Deferral Program.

          (b)     Irrevocability of Deferral Election. Except as provided in Sections
2.6(c) or (d) or Section 2.9, an election to defer the payment of all or a
portion of a Participant’s Deferred Units or Deferred Stock Units made
pursuant to Section 2.6(a) shall be irrevocable once submitted to the
Administrator or his or her designee.

          (c)     Rescission of Deferral Election Prior to the Expiration of the
Holding Period. An optional deferral election may be rescinded at the request
of the Participant only (i) prior to the expiration of the Holding Period with
respect to any grant of Deferred Units or Deferred Stock Units, and (ii) if
the Administrator, in his or her sole discretion and upon evidence of such
basis that he or she finds persuasive (including a material applicable change
in the Participant’s U.S. Federal and/or foreign income tax rate during the
period between the deferral election and the expiration of the Holding
Period), agrees to the rescission of the election. In the event of a
rescission under this Section 2.6(c), no deferral will be effected under the
Plan and the Participant will be paid the Deferred Units or Deferred Stock
Units in accordance with Section 2.7(a).

          (d)     Rescission of Deferral Election Caused by an Adverse Tax
Determination. Notwithstanding the provisions of Section 2.6(a), a deferral
election may be rescinded at any time if (i) a final determination is made by
a court or other governmental body of competent jurisdiction that the election
was ineffective to defer income for purposes of U.S. Federal, state, local or
foreign income taxation and the time for appeal from this determination has
expired, and (ii) the Administrator, in his or her sole discretion, decides,
upon the Participant’s request and upon evidence of the occurrence of the
events described in clause (i) hereof that he or she finds persuasive, to
rescind the election. Upon such rescission, the relevant Account Balance will
be paid to the Participant as soon as practicable as provided herein.

          Section 2.7     Payment of Units Optionally Deferred.

6

 

          (a)     Regular Payment Elections. A Participant’s Account Balance will be
paid by ML & Co., as elected by the Participant at the time of his or her
optional deferral election, either in a single payment to be made, or in the
number of annual installment payments (not to exceed 15) chosen by the
Participant to commence, (i) in the month following the month of the
Participant’s End of Service Date or death, (ii) in any month and year
selected by the Participant after the scheduled expiration of the Holding
Period (i.e., without taking into account the possibility of Early Separation,
death or Disability), or (iii) in any month in the calendar year following the
Participant’s End of Service Date, but in no event may the date elected under
clause (i), (ii) or (iii) result in the payment (in the case of a single
payment) or commencement of payments (in the case of installment payments)
later than the month following the Participant’s 72nd birthday. The amount of
each annual installment payment, if applicable, shall be determined by
multiplying the Account Balance as of the last day of the month immediately
preceding the month in which the payment is to be made by a fraction, the
numerator of which is one and the denominator of which is the number of
remaining installment payments (including the installment payment to be made)
and rounding the result to the nearest whole Deferred Unit, Deferred Stock
Unit or cent, as the case may be.

          (b)     Form of Payment. Deferred Units and Deferred Stock Units payable
pursuant to this Section 2.7 will be paid in shares of Common Stock. One
share of Common Stock will be delivered for each unit to be paid, after
rounding any fractional unit upwards to the nearest whole share.

          (c)     Death Prior to Payment. If the Participant dies prior to payment of
any or all amounts optionally deferred, then the Account Balance will be paid
to the Participant’s beneficiary in accordance with the Participant’s election
of either installment payments, or a single payment, provided,
however, that, in the event that a beneficiary of the Participant’s
Account Balance is the Participant’s estate or is otherwise not a natural
person, then (i) if the Participant has elected a regular payment election
pursuant to Section 2.7(a), the applicable portion of the Account Balance will
be paid in a single payment to such beneficiary, and (ii) if the Participant
has elected installment payments, the applicable portion of the Account
Balance will continue to be paid as installment payments, but only to a single
person consisting of the administrator or executor of the Participant’s estate
or another person lawfully designated by the administrator or executor (and in
the event no such person is designated within a reasonable time, payment will
be made in a lump sum).

          (d)     Discretion to Alter Payment Date. Notwithstanding the other
provisions of this Section 2.7, if the Participant ceases to be a Director for
any reason, the Administrator may, in his or her sole discretion, direct that
the Account Balance (but not any subsequent optional deferral thereof), be
paid at some other time or that it be paid in installments; provided,
that no such direction that adversely affects the rights of the Participant or
his or her beneficiary under this Plan shall be implemented without the
consent of the affected Participant or beneficiary. This direction may be
revoked by the Administrator at any time in his or her sole discretion.

          (e)     Hardship Distributions. ML & Co. may pay to the Participant, on such
terms and conditions as the Administrator may establish, such part or all of
the Account Balance, as the Administrator may, in his or her sole discretion
based upon substantial evidence submitted by the Participant, determine
necessary to alleviate hardship caused by an unanticipated emergency or
necessity outside of the Participant’s control affecting the Participant’s
personal or family affairs. Such payment will be made only at the
Participant’s written request and with the express approval of the
Administrator and will be made on the date selected by the Administrator in
his or her sole discretion. The balance of the Account, if any, will continue
to be governed by the terms of this Plan. Hardship shall be deemed to exist
only on account of expenses for medical care (described in Code Section
213(d)) of the Participant, the Participant’s spouse or the Participant’s
dependents (described in Code Section 152); payment of unreimbursed tuition
and related educational fees for the Participant, the Participant’s spouse or
the Participant’s dependents; the need to prevent the Participant’s eviction
from, or foreclosure on, the Participant’s principal residence; unreimbursed
damages resulting from a natural disaster; or such other financial need deemed
by the Administrator in his or her sole discretion to be immediate and
substantial.

          Section 2.8     Beneficiary.

7

 

          (a)     Designation of Beneficiary. The Participant may designate, in a
writing delivered to the Administrator or his or her designee before the
Participant’s death, a beneficiary (which may be a charity or other entity) to
receive payments under the Plan in the event of the Participant’s death. The
Participant may also designate a contingent beneficiary to receive payments
under the Plan if the primary beneficiary does not survive the Participant.
The Participant may designate more than one person as the Participant’s
beneficiary or contingent beneficiary, in which case (i) no contingent
beneficiary would receive any payment unless all of the primary beneficiaries
predeceased the Participant, and (ii) the surviving beneficiaries in any class
shall share in any payments in proportion to the percentages of interest
assigned to them by the Participant.

          (b)     Change in Beneficiary. The Participant may change his or her
beneficiary or contingent beneficiary (without the consent of any prior
beneficiary) in a writing delivered to the Administrator or his or her
designee before the Participant’s death. Unless the Participant states
otherwise in writing, any change in beneficiary or contingent beneficiary will
automatically revoke such prior designations of the Participant’s beneficiary
or of the Participant’s contingent beneficiary, as the case may be, under this
Plan only; and any designations under other deferral agreements or plans of
the Company will remain unaffected.

          (c)     Default Beneficiary. In the event a Participant does not designate a
beneficiary, or no designated beneficiary survives the Participant, the
Participant’s beneficiary shall be the Participant’s surviving spouse, if the
Participant is married at the time of his or her death and not subject to a
court-approved agreement or court decree of separation, or otherwise the
person or persons designated to receive benefits on account of the
Participant’s death under the ML & Co. pre-retirement death benefit for
Non-Employee Directors, unless the rights to such benefit have been assigned,
in which case any amounts payable to the Participant’s beneficiary under the
Plan will be paid to the Participant’s estate.

          (d)     If the Beneficiary Dies During Payment. If a beneficiary who is
receiving or is entitled to receive payments hereunder dies after the
Participant but before all the payments have been made, the portion of the
Account Balance to which that beneficiary was entitled will be paid as soon as
practicable in a single payment to such beneficiary’s estate and not to any
contingent beneficiary the Participant may have designated; provided,
however, that if the beneficiary was receiving installment payments,
the applicable portion of the Account Balance will continue to be paid as
installment payments but only to a single person consisting of the
administrator or executor of the beneficiary’s estate or another person
lawfully designated by the administrator or executor (and in the event no such
person is designated within a reasonable time, payment will be made in a lump
sum).

          Section 2.9     Domestic Relations Orders.

          Notwithstanding the Participant’s elections hereunder, ML & Co. will pay
to, or to the Participant for the benefit of, the Participant’s spouse or
former spouse the portion of the Participant’s Account Balance specified in a
valid court order entered in a domestic relations proceeding involving the
Participant’s divorce or legal separation. Any such payment will be made net
of any amounts the Company may be required to withhold under applicable
federal, state or local law.

          Section 2.10    Withholding of Taxes.

          ML & Co. will deduct from any payment to be made or deferred hereunder
any U.S. Federal, state or local or foreign income or employment taxes
required by law to be withheld or require the Participant or the Participant’s
beneficiary to pay any amount, or the balance of any amount, required to be
withheld.

Article III — Adjustment of Accounts

          Section 3.1     Adjustment of Accounts.

          (a)     Dividend Equivalents. Whenever a cash dividend is paid on a share of
Common Stock, a Participant’s Deferred Units and Deferred Stock Units will be
adjusted by adding to the Deferred Units or Deferred Stock Units, as
applicable, the number of Deferred Units or Deferred Stock Units determined by
multiplying the per share amount of the cash dividend by the Deferred Units or
Deferred Stock Units, as

8

 

applicable, on the record date for the cash dividend, dividing the result by
the price per share of Common Stock used for purposes of the reinvestment of
such cash dividend in the Merrill Lynch & Co., Inc. Dividend Reinvestment
Program currently administered by Business Information Services (or their
functional successor), or if at any time there is no Dividend Reinvestment
Program, the Daily Market Price of a share of Common Stock on the date the
cash dividend is paid, and rounding the result to the nearest 1/100th of a
Deferred Unit or Deferred Stock Unit as the case may be (with .005 being
rounded upwards); provided that, if the number of a Participant’s
Deferred Units or Deferred Stock Units is reduced to zero in accordance with
the Plan between the record date and the payment date for such cash dividend,
then, in lieu of such adjustment to the Participant’s Account, the dividend
equivalent amount with respect to such record date will be determined by
multiplying the per share amount of the cash dividend by the Deferred Units or
Deferred Stock Units in the Account on the record date for the cash dividend
and rounding the result to the nearest whole cent. This amount shall be paid
to the Participant in cash at the same time as such cash dividend is paid to
the holders of the Common Stock.

          (b)     Changes in Capitalization. Any other provision of the Plan to the
contrary notwithstanding, if any change shall occur in or affect shares of
Common Stock (or the Rights or Junior Preferred Stock) on account of a merger,
consolidation, reorganization, stock dividend, stock split or combination,
reclassification, recapitalization, or distribution to holders of shares of
Common Stock (other than cash dividends), including, without limitation, a
merger or other reorganization event in which the shares of Common Stock cease
to exist, then appropriate adjustments shall be made, without any action by
the Board of Directors, to the Deferred Units, Deferred Stock Units and Stock
Options, as shall be necessary to maintain the proportionate interest of the
Participants and to preserve, without increasing, the value of Stock Options
or the Account Balance. In the event of a change in the presently authorized
shares of Common Stock that is limited to a change in the designation thereof
or a change of authorized shares with par value into the same number of shares
with a different par value or into the same number of shares without par
value, the shares resulting from any such change shall be deemed to be shares
of Common Stock within the meaning of the Plan.

Article IV — Status of Accounts

          Section 4.1     No Trust or Fund Created; General Creditor Status.

          Nothing contained herein and no action taken pursuant hereto will be
construed to create a trust or separate fund of any kind or a fiduciary
relationship between ML & Co. and any Participant, the Participant’s
beneficiary or estate, or any other person. Title to and beneficial ownership
of any funds represented by the Account Balance will at all times remain in ML
& Co.; such funds will continue for all purposes to be a part of the general
funds of ML & Co. and may be used for any corporate purpose. No person will,
by virtue of the provisions of this Plan, have any interest whatsoever in any
specific assets of the Company. TO THE EXTENT THAT ANY PERSON ACQUIRES A
RIGHT TO RECEIVE PAYMENTS FROM ML & CO. UNDER THIS PLAN, SUCH RIGHT WILL BE NO
GREATER THAN THE RIGHT OF ANY UNSECURED GENERAL CREDITOR OF ML & CO.

          Section 4.2     Non-Assignability.

          Except as provided in Section 2.5(d)(iv), a Participant’s right or the
right of any other person to his or her Account Balance or any other benefits
hereunder cannot be assigned, alienated, sold, garnished, transferred,
pledged, or encumbered except by a written designation of beneficiary under
this Plan, by written will, or by the laws of descent and distribution.

          Section 4.3     Effect on Benefits Under Pension and Welfare Benefit Plans.

          The effect of the grants, deferrals and payments under the Plan on
pension and welfare benefit plans in which the Participant may be a
participant will depend upon the provisions of each such plan, as amended from
time to time.

Article V — Change in Control

          Section 5.1     Payment of Account Balance upon Change in Control.

9

 

          (a)     Payment of Account Balance. Notwithstanding any other provision of
this Plan, in the event that (i) ML & Co. receives a Tender Offer Statement on
Schedule 14D-1 under the Securities Exchange Act of 1934 relating to a Tender
Offer, or (ii) a Change in Control shall occur, the Participant’s Account
Balance, will be paid to the Participant in a lump sum promptly after the
receipt of such Tender Offer Statement or the occurrence of such Change in
Control, and in any event, not later than 30 days thereafter.

          (b)     Manner of Payment. Payment of Account Balances pursuant to Section
5.1(a) shall be made in the following manner:

          (i)     With respect to Deferred Units and Deferred Stock Units, payment
shall be made in cash and shall be calculated as if any applicable Holding
Period had expired. The amount of the cash payment shall be determined by
multiplying the number of Deferred Units and Deferred Stock Units in the
Participant’s Account by the Daily Market Price per share of Common Stock on
the date of the event specified in Section 5.1(a)(i) or (ii), as the case may
be, or, if higher, the highest Daily Market Price per share of Common Stock on
any day during the 90-day period ending on such date.

          (ii)     With respect to Stock Options, for each underlying share of Common
Stock, the excess of the Daily Market Price of a share of Common Stock on the
date of the event specified in Section 5.1(a)(i) or (ii), as the case
may be, or, if higher, the highest Daily Market Price per share of Common
Stock on any day during the 90-day period ending on such date, over the per
share exercise price for such Stock Option;

Article VI — Administration of the Plan

          Section 6.1     Powers of the Administrator.

          The Administrator has full power and authority to interpret, construe,
and administer this Plan. The Administrator’s interpretations and
construction hereof, and actions hereunder, including any determinations
regarding the amount or recipient of any payments, will be binding and
conclusive on all persons for all purposes. The Administrator will not be
liable to any person for any action taken or omitted in connection with the
interpretation and administration of this Plan unless attributable to his or
her willful misconduct or lack of good faith. The Administrator may designate
persons to carry out the specified responsibilities of the Administrator and
shall not be liable for any act or omission of a person as designated.

          Section 6.2     Payments on Behalf of an Incompetent.

          If the Administrator finds that any person who is presently entitled to
any payment hereunder is a minor or is unable to care for his or her affairs
because of disability or incompetency, payment of the Account Balances may be
made to anyone found by the Administrator to be the committee or other
authorized representative of such person, or to be otherwise entitled to such
payment, in the manner and under the conditions that the Administrator
determines. Such payment will be a complete discharge of the liabilities of
ML & Co. hereunder with respect to the amounts so paid.

          Section 6.3     Corporate Books and Records Controlling.

          The books and records of the Company will be controlling in the event a
question arises hereunder concerning Account Balances, deferral elections,
beneficiary designations, or any other matters.

Article VII — Miscellaneous Provisions

          Section 7.1     Litigation.

          The Company shall have the right to contest, at its expense, any ruling
or decision, administrative or judicial, on an issue that is related to the
Plan and that the Administrator believes to be important to Participants, and
to conduct any such contest or any litigation arising therefrom to a final
decision.

10

 

          Section 7.2     Headings Are Not Controlling.

          The headings contained in this Plan are for convenience only and will not
control or affect the meaning or construction of any of the terms or
provisions of this Plan.

          Section 7.3     Governing Law.

          To the extent not preempted by applicable U.S. Federal law, this Plan
will be construed in accordance with and governed by the laws of the State of
New York as to all matters, including, but not limited to, matters of
validity, construction, and performance.

          Section 7.4     Amendment and Termination.

          The Board of Directors, or, if permitted pursuant to Rule 16b-3 under the
Exchange Act, the Executive Committee may amend or terminate this Plan at any
time, provided that no amendment or termination may be made that would
adversely affect the right of a Participant to his or her Account Balance as
of the date of such amendment or termination.

Article VIII — Effective Date

          The initial plan was effective on August 1, 1996, the amended Plan shall
be effective as of February 16, 2001.

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}]]